Total Payments
$30,823
2024 Payments
$13.23
Companies
9
Transactions
72
Medicare Patients
343
Medicare Billing
$48,825
Payment Breakdown by Category
Consulting$17,674 (57.3%)
Other$7,656 (24.8%)
Research$3,079 (10.0%)
Food & Beverage$1,472 (4.8%)
Travel$941.84 (3.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $17,674 | 5 | 57.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,656 | 4 | 24.8% |
| Unspecified | $3,079 | 38 | 10.0% |
| Food and Beverage | $1,472 | 20 | 4.8% |
| Travel and Lodging | $941.84 | 5 | 3.1% |
Payments by Type
General
$27,744
34 transactions
Research
$3,079
38 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $10,338 | 14 | $0 (2024) |
| GENZYME CORPORATION | $9,065 | 9 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $7,656 | 4 | $0 (2021) |
| Regeneron Pharmaceuticals, Inc. | $3,163 | 39 | $0 (2023) |
| Genentech, Inc. | $191.25 | 1 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $169.62 | 2 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $99.89 | 1 | $0 (2018) |
| Sientra, Inc. | $89.31 | 1 | $0 (2019) |
| ConvaTec Inc. | $51.01 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13.23 | 1 | Novartis Pharmaceuticals Corporation ($13.23) |
| 2023 | $1,130 | 9 | Regeneron Pharmaceuticals, Inc. ($1,130) |
| 2022 | $3,436 | 16 | Novartis Pharmaceuticals Corporation ($2,475) |
| 2021 | $4,694 | 13 | SANOFI-AVENTIS U.S. LLC ($3,896) |
| 2020 | $8,882 | 8 | SANOFI-AVENTIS U.S. LLC ($3,760) |
| 2019 | $7,298 | 12 | GENZYME CORPORATION ($6,870) |
| 2018 | $190.20 | 3 | Regeneron Healthcare Solutions, Inc. ($99.89) |
| 2017 | $5,182 | 10 | Novartis Pharmaceuticals Corporation ($5,090) |
All Payment Transactions
72 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/11/2024 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: Oncology | ||||||
| 11/30/2023 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | — | In-kind items and services | $575.94 | Research |
| Study: LIBTAYO CLINICAL PUBLICATION PROGRAM • Category: ONCOLOGY | ||||||
| 08/12/2023 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | — | In-kind items and services | $95.97 | Research |
| Study: LIBTAYO CLINICAL PUBLICATION PROGRAM • Category: ONCOLOGY | ||||||
| 04/28/2023 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | — | In-kind items and services | $22.25 | Research |
| Study: LIBTAYO CLINICAL PUBLICATION PROGRAM • Category: ONCOLOGY | ||||||
| 02/19/2023 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | — | In-kind items and services | $85.24 | Research |
| Study: LIBTAYO CLINICAL PUBLICATION PROGRAM • Category: ONCOLOGY | ||||||
| 01/20/2023 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | — | In-kind items and services | $85.24 | Research |
| Study: LIBTAYO CLINICAL PUBLICATION PROGRAM • Category: ONCOLOGY | ||||||
| 01/20/2023 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | — | In-kind items and services | $37.89 | Research |
| Study: LIBTAYO CLINICAL PUBLICATION PROGRAM • Category: ONCOLOGY | ||||||
| 01/12/2023 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | — | In-kind items and services | $113.71 | Research |
| Study: LIBTAYO CLINICAL PUBLICATION PROGRAM • Category: ONCOLOGY | ||||||
| 01/12/2023 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | — | In-kind items and services | $85.24 | Research |
| Study: LIBTAYO CLINICAL PUBLICATION PROGRAM • Category: ONCOLOGY | ||||||
| 01/10/2023 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | — | In-kind items and services | $28.09 | Research |
| Study: LIBTAYO CLINICAL PUBLICATION PROGRAM • Category: ONCOLOGY | ||||||
| 12/18/2022 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | — | In-kind items and services | $21.35 | Research |
| Study: LIBTAYO CLINICAL PUBLICATION PROGRAM • Category: ONCOLOGY | ||||||
| 12/15/2022 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | — | In-kind items and services | $21.35 | Research |
| Study: LIBTAYO CLINICAL PUBLICATION PROGRAM • Category: ONCOLOGY | ||||||
| 12/05/2022 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | — | In-kind items and services | $21.35 | Research |
| Study: LIBTAYO CLINICAL PUBLICATION PROGRAM • Category: ONCOLOGY | ||||||
| 11/02/2022 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | — | In-kind items and services | $93.99 | Research |
| Study: LIBTAYO CLINICAL PUBLICATION PROGRAM • Category: ONCOLOGY | ||||||
| 10/27/2022 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | — | In-kind items and services | $29.81 | Research |
| Study: LIBTAYO CLINICAL PUBLICATION PROGRAM • Category: ONCOLOGY | ||||||
| 10/20/2022 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | — | In-kind items and services | $93.99 | Research |
| Study: LIBTAYO CLINICAL PUBLICATION PROGRAM • Category: ONCOLOGY | ||||||
| 09/23/2022 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | — | In-kind items and services | $20.13 | Research |
| Study: LIBTAYO CLINICAL PUBLICATION PROGRAM • Category: ONCOLOGY | ||||||
| 09/23/2022 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | — | In-kind items and services | $20.13 | Research |
| Study: LIBTAYO CLINICAL PUBLICATION PROGRAM • Category: ONCOLOGY | ||||||
| 09/14/2022 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | — | In-kind items and services | $88.62 | Research |
| Study: LIBTAYO CLINICAL PUBLICATION PROGRAM • Category: ONCOLOGY | ||||||
| 09/14/2022 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | — | In-kind items and services | $88.62 | Research |
| Study: LIBTAYO CLINICAL PUBLICATION PROGRAM • Category: ONCOLOGY | ||||||
| 05/03/2022 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | — | In-kind items and services | $17.89 | Research |
| Study: LIBTAYO CLINICAL PUBLICATION PROGRAM • Category: ONCOLOGY | ||||||
| 04/22/2022 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | — | In-kind items and services | $111.48 | Research |
| Study: LIBTAYO CLINICAL PUBLICATION PROGRAM • Category: ONCOLOGY | ||||||
| 04/11/2022 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | — | In-kind items and services | $210.60 | Research |
| Study: LIBTAYO CLINICAL PUBLICATION PROGRAM • Category: ONCOLOGY | ||||||
| 03/28/2022 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | — | In-kind items and services | $21.35 | Research |
| Study: LIBTAYO CLINICAL PUBLICATION PROGRAM • Category: ONCOLOGY | ||||||
| 03/03/2022 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug) | Consulting Fee | Cash or cash equivalent | $2,475.00 | General |
| Category: ONCOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| LIBTAYO CLINICAL PUBLICATION PROGRAM | Regeneron Pharmaceuticals, Inc. | $3,079 | 38 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 90 | 90 | $109,460 | $20,979 |
| 2022 | 2 | 24 | 26 | $16,510 | $3,041 |
| 2021 | 3 | 34 | 35 | $19,232 | $3,518 |
| 2020 | 7 | 195 | 203 | $116,740 | $21,287 |
Total Patients
343
Total Services
354
Medicare Billing
$48,825
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 21016 | Extensive removal of growth of face or scalp, 2.0 cm or more | Office | 2023 | 13 | 13 | $44,901 | $9,609 | 21.4% |
| 15120 | Partial thickness self skin graft to face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 100.0 sq cm or 1% body area for infants and children, or less | Office | 2023 | 13 | 13 | $37,364 | $4,800 | 12.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $7,313 | $2,920 | 39.9% |
| 38900 | Imaging of lymph nodes during surgery | Office | 2023 | 15 | 15 | $7,402 | $1,738 | 23.5% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 11 | 11 | $10,530 | $1,047 | 9.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 11 | $1,950 | $865.59 | 44.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 13 | 13 | $4,264 | $1,836 | 43.1% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2022 | 11 | 13 | $12,246 | $1,205 | 9.8% |
| 11606 | Removal of malignant growth (over 4.0 centimeters) of the trunk, arms, or legs | Facility | 2021 | 11 | 12 | $15,228 | $2,364 | 15.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 12 | 12 | $2,508 | $726.70 | 29.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 11 | 11 | $1,496 | $427.31 | 28.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 94 | 94 | $32,618 | $9,059 | 27.8% |
| 11606 | Removal of malignant growth (over 4.0 centimeters) of the trunk, arms, or legs | Facility | 2020 | 13 | 14 | $17,766 | $2,605 | 14.7% |
| 13121 | Repair of wound (2.6 to 7.5 centimeters) of scalp, arms, and/or legs | Facility | 2020 | 17 | 17 | $22,083 | $2,452 | 11.1% |
| 38900 | Lymph node imaging during surgery | Facility | 2020 | 19 | 19 | $13,167 | $2,183 | 16.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 26 | 33 | $7,092 | $1,945 | 27.4% |
| 13101 | Repair of wound (2.6 to 7.5 centimeters) of trunk | Facility | 2020 | 11 | 11 | $12,419 | $1,715 | 13.8% |
| 11603 | Removal of malignant growth (2.1 to 3.0 centimeters) of the trunk, arms, or legs | Facility | 2020 | 15 | 15 | $11,595 | $1,329 | 11.5% |
About Dr. Rogerio Neves, MD
Dr. Rogerio Neves, MD is a Plastic Surgery healthcare provider based in Tampa, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/08/2007. The National Provider Identifier (NPI) number assigned to this provider is 1548391980.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rogerio Neves, MD has received a total of $30,823 in payments from pharmaceutical and medical device companies, with $13.23 received in 2024. These payments were reported across 72 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($17,674).
As a Medicare-enrolled provider, Neves has provided services to 343 Medicare beneficiaries, totaling 354 services with total Medicare billing of $48,825. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Plastic Surgery
- Other Specialties Plastic Surgery, Plastic Surgery
- Location Tampa, FL
- Active Since 03/08/2007
- Last Updated 12/09/2021
- Taxonomy Code 208200000X
- Entity Type Individual
- NPI Number 1548391980
Products in Payments
- LIBTAYO (Biological) $12,930
- LIBTAYO (Drug) $6,870
- MEKINIST (Drug) $5,292
- TAFINLAR (Drug) $5,045
- LIBTAYO CEMIPLIMAB-RWLC INJECTION (Biological) $99.89
- SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT (Device) $89.31
- AQUACEL (Device) $51.01
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Plastic Surgery Doctors in Tampa
Dr. Melanie Aya-Ay, M.d, M.D
Plastic Surgery — Payments: $161,334
Plastic Surgery $161,334
Dr. Moriah Moffitt, M.d, M.D
Plastic Surgery — Payments: $43,380
Plastic Surgery $43,380
Daniel Diaco, M.d, M.D
Plastic Surgery — Payments: $27,154
Plastic Surgery $27,154
Dr. Michael Harrington, M.d, M.D
Plastic Surgery — Payments: $19,467
Plastic Surgery $19,467
Stanley Castor, Md, MD
Plastic Surgery — Payments: $12,275
Plastic Surgery $12,275
Anthony Watt, M.d, M.D
Plastic Surgery — Payments: $10,136
Plastic Surgery $10,136